• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Vanda Contests FDA Rejection of Gastroparesis Drug, Slams ‘Delayed’ Decision

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 20, 2024 at 11:33: AM
via Vanda Pharmaceuticals on Thursday announced that the regulator declined to approve its application, a decision the company says was delayed by more than 185 days and failed to satisfy the requirements of the Federal Drug and Cosmetic Act.

article source
 

<



Similar threads

cafead
Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal
Replies
1
Views
25
Pharma/Biotech Companies - In the News
anonymous
cafead
Future Pak withdraws offer to buy Vanda Pharmaceuticals
Replies
0
Views
24
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vanda rejects buyout offers, pans &#039;opportunistic attempts&#039; at securing its shares at a discount
Replies
0
Views
51
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vanda, after rejecting Future Pak offer, gets $466M takeout bid from Cycle Pharma
Replies
0
Views
59
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vanda Pharmaceuticals reports positive data from motion sickness trial
Replies
0
Views
60
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote